Savant Capital LLC Trims Stock Position in Colgate-Palmolive Company $CL

Savant Capital LLC lessened its stake in shares of Colgate-Palmolive Company (NYSE:CL) by 18.0% in the 4th quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The fund owned 28,816 shares of the company’s stock after selling 6,317 shares during the quarter. Savant Capital LLC’s holdings in Colgate-Palmolive were worth $2,277,000 at the end of the most recent reporting period.

A number of other institutional investors have also modified their holdings of the business. HighPoint Advisor Group LLC increased its holdings in shares of Colgate-Palmolive by 0.7% in the 4th quarter. HighPoint Advisor Group LLC now owns 15,877 shares of the company’s stock valued at $1,255,000 after acquiring an additional 109 shares during the period. Sunpointe LLC increased its holdings in shares of Colgate-Palmolive by 4.0% in the 4th quarter. Sunpointe LLC now owns 3,056 shares of the company’s stock valued at $241,000 after acquiring an additional 117 shares during the period. Capital Advisors Inc. OK increased its holdings in shares of Colgate-Palmolive by 1.4% in the 4th quarter. Capital Advisors Inc. OK now owns 9,595 shares of the company’s stock valued at $758,000 after acquiring an additional 129 shares during the period. Stratos Wealth Advisors LLC increased its holdings in shares of Colgate-Palmolive by 4.5% in the 3rd quarter. Stratos Wealth Advisors LLC now owns 3,015 shares of the company’s stock valued at $241,000 after acquiring an additional 130 shares during the period. Finally, CYBER HORNET ETFs LLC increased its holdings in shares of Colgate-Palmolive by 5.9% in the 4th quarter. CYBER HORNET ETFs LLC now owns 2,357 shares of the company’s stock valued at $186,000 after acquiring an additional 131 shares during the period. 80.41% of the stock is owned by institutional investors and hedge funds.

Colgate-Palmolive Stock Up 0.1%

Shares of NYSE:CL opened at $90.26 on Monday. The company has a market cap of $72.22 billion, a price-to-earnings ratio of 35.12, a PEG ratio of 4.68 and a beta of 0.33. The firm’s 50-day simple moving average is $86.29 and its 200-day simple moving average is $85.69. The company has a quick ratio of 0.67, a current ratio of 1.02 and a debt-to-equity ratio of 16.33. Colgate-Palmolive Company has a fifty-two week low of $74.54 and a fifty-two week high of $99.33.

Colgate-Palmolive (NYSE:CL) last issued its earnings results on Friday, May 1st. The company reported $0.97 earnings per share for the quarter, beating the consensus estimate of $0.94 by $0.03. The business had revenue of $5.32 billion for the quarter, compared to the consensus estimate of $5.22 billion. Colgate-Palmolive had a net margin of 10.04% and a return on equity of 386.76%. The business’s quarterly revenue was up 8.4% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.91 earnings per share. As a group, equities research analysts predict that Colgate-Palmolive Company will post 3.82 earnings per share for the current year.

Colgate-Palmolive Increases Dividend

The business also recently declared a quarterly dividend, which was paid on Friday, May 15th. Stockholders of record on Monday, April 20th were paid a dividend of $0.53 per share. This is a boost from Colgate-Palmolive’s previous quarterly dividend of $0.52. The ex-dividend date of this dividend was Monday, April 20th. This represents a $2.12 dividend on an annualized basis and a dividend yield of 2.3%. Colgate-Palmolive’s dividend payout ratio is currently 82.49%.

Analyst Ratings Changes

A number of equities analysts have recently commented on the stock. The Goldman Sachs Group reaffirmed a “buy” rating on shares of Colgate-Palmolive in a report on Friday, May 1st. Bank of America cut their target price on shares of Colgate-Palmolive from $105.00 to $102.00 and set a “buy” rating on the stock in a report on Friday, April 10th. Barclays lifted their target price on shares of Colgate-Palmolive from $79.00 to $80.00 and gave the company an “equal weight” rating in a report on Tuesday, May 5th. TD Cowen reaffirmed a “hold” rating and issued a $85.00 target price on shares of Colgate-Palmolive in a report on Tuesday, March 31st. Finally, Piper Sandler cut their target price on shares of Colgate-Palmolive from $96.00 to $92.00 and set an “overweight” rating on the stock in a report on Wednesday, April 8th. Twelve research analysts have rated the stock with a Buy rating and six have assigned a Hold rating to the stock. According to data from MarketBeat, Colgate-Palmolive presently has an average rating of “Moderate Buy” and a consensus target price of $95.88.

Colgate-Palmolive Company Profile

Colgate-Palmolive Company is a global consumer products company with a long history in household and personal care categories. The business traces its roots to the early 19th century and has evolved into a multinational manufacturer and marketer of everyday consumer goods focused on health, hygiene and home care.

The company’s core activities center on oral care, personal care, home care and pet nutrition. Its product portfolio includes toothpaste, toothbrushes and mouthwash in oral care; soaps, body washes and deodorants in personal care; dishwashing liquids, surface cleaners and other household products in home care; and scientifically formulated pet foods under its pet nutrition business.